Gamida Cell Ltd Asset Turnover Ratio (GMDA), as of first quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Gamida Cell Ltd   (NASDAQ: GMDA)
 

Gamida Cell Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Gamida Cell Ltd asset turnover ratio, the ability of Gamida Cell Ltd 's assets to generate revenue in the first quarter 2024, increased sequentially to 0.02 in the first quarter (Mar 31 2024), GMDA's balance sheet remain strong.

Within sector Gamida Cell Ltd achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the First Quarter 2024 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GMDA Asset Turnover Ratio (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Asset Change -48.31 % -61.79 % -29.61 % -36.49 % -10.82 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.02 0.01 0 - -
GMDA's Total Ranking # # # # #
Seq. Asset Change -12.43 % -17.89 % 4.63 % -31.3 % -35.27 %
Seq. Revenue Change -19.89 % 65.08 % - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




GMDA Company Profile • Back to GMDA Efficiency Comparisons • Compare GMDA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2024 Assets at quarter ending Mar 31 2024
Omniab Inc   0.06 $ 21.046  Millions$ 381.182  Millions
C4 Therapeutics Inc   0.05 $ 20.036  Millions$ 370.711  Millions
Tscan Therapeutics Inc   0.05 $ 14.812  Millions$ 280.321  Millions
Viskase Holdings inc   0.05 $ 2.461  Millions$ 47.050  Millions
60 Degrees Pharmaceuticals Inc   0.05 $ 0.342  Millions$ 6.546  Millions
Femasys Inc   0.05 $ 1.049  Millions$ 20.324  Millions
Foxo Technologies Inc   0.05 $ 0.139  Millions$ 2.724  Millions
Synlogic Inc   0.05 $ 3.205  Millions$ 64.286  Millions
Anaptysbio Inc   0.05 $ 22.962  Millions$ 465.663  Millions
4d Molecular Therapeutics Inc   0.05 $ 20.453  Millions$ 420.973  Millions
Sab Biotherapeutics Inc   0.05 $ 2.602  Millions$ 54.773  Millions
Northwest Biotherapeutics Inc  0.05 $ 1.336  Millions$ 29.091  Millions
Astrotech Corp  0.05 $ 2.004  Millions$ 43.835  Millions
Enzo Biochem Inc  0.04 $ 4.721  Millions$ 105.184  Millions
Inovio Pharmaceuticals Inc   0.04 $ 8.143  Millions$ 181.550  Millions
Armata Pharmaceuticals Inc   0.04 $ 4.699  Millions$ 108.173  Millions
Cardiff Oncology Inc   0.04 $ 3.657  Millions$ 85.396  Millions
Intellia Therapeutics Inc   0.04 $ 52.604  Millions$ 1,281.789  Millions
Bio Green Med Solution Inc   0.04 $ 0.449  Millions$ 11.115  Millions
Vir Biotechnology Inc   0.04 $ 79.599  Millions$ 2,000.450  Millions
Relay Therapeutics Inc   0.04 $ 35.327  Millions$ 888.599  Millions
Nexalin Technology Inc   0.04 $ 0.159  Millions$ 4.019  Millions
Motus Gi Holdings Inc   0.04 $ 0.327  Millions$ 8.630  Millions
Meiragtx Holdings Plc  0.04 $ 11.380  Millions$ 303.359  Millions
Vystar Corporation  0.04 $ 0.154  Millions$ 4.192  Millions
Lumos Pharma Inc   0.04 $ 1.525  Millions$ 43.210  Millions
Volitionrx Limited  0.03 $ 0.797  Millions$ 23.247  Millions
Kronos Bio Inc   0.03 $ 7.587  Millions$ 223.717  Millions
Stoke Therapeutics Inc   0.03 $ 7.844  Millions$ 232.583  Millions
Seer Inc   0.03 $ 14.814  Millions$ 441.070  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.